Cardiovascular Rounds

Recent Posts

Here's one idea for securing CV imaging referrals

on February 13, 2013  |  Permalink

Topics: Cardiovascular, Service Lines, Imaging, Service Line Growth, Volume Growth, Strategy, Referral Management, Physician Issues, Quality, Performance Improvement, Physician Marketing, Marketing

Megan Tooley, Cardiovascular Roundtable

Recently, members have been asking us for strategies to strengthen their relationships with referring physicians, particularly for CV diagnostic testing. In light of declining volumes for CV services, it’s crucial to make sure you are capturing referrals for these front-end services.

We offer many best practices for enhancing CV market capture in our ongoing national meeting presentation "CV Imaging as the Nexus of Growth" and our study CV Marketing Strategy. But today I want to highlight another organization that is strategically marketing a new service that ensures CV imaging report quality to strengthen high-priority referral relationships.

Continue reading:
Here's one idea for securing CV imaging referrals

So you're not a TAVR program—Now what?

on January 14, 2013  |  Permalink

Topics: Cardiovascular, Service Lines, Cardiac Cath, Cardiac Surgery, Regionalization and Networks, Strategy, Service Line Growth, Volume Growth, Technology Assessment, Planning, Program Infrastructure, Business Development

Megan Tooley, Cardiovascular Roundtable

There is no question the emergence of transcatheter valve technologies—specifically transcatheter aortic valve replacement (TAVR)—has elicited unprecedented excitement from the cardiovascular community in recent years. However, despite this enthusiasm, the reality is only a portion of hospitals will meet the strict resource and volume requirements necessary to become TAVR sites in the near future.

This may leave many of you wondering, “So what if we’re not a TAVR program? Is there still a place for us in the valve market?” You’re not alone, and as we explore in our national meeting series, your options for treating valve disease and disorders do not end at TAVR.

Learn how one Roundtable member is ensuring their patients have access to a full range of valve services—even if they’re not the TAVR program.

Continue reading:
So you're not a TAVR program—Now what?

Cardiac surgery volume projections: CABG to decline 3% over next five years

Dana Pfenninger Khan on August 2, 2012  |  Permalink

Topics: Cardiac Surgery, Cardiovascular, Service Lines, Market Assessment, Planning, Strategy, Service Line Growth, Volume Growth

We've recently received numerous requests from our membership looking for information on anticipated trends for CABG and valve procedures. 

Read on to learn more our current forecasts for these procedures, as well as some insights on the productivity and practice portfolio of today’s cardiac surgeons.

Continue reading:
Cardiac surgery volume projections: CABG to decline 3% over next five years

Tell Us What You Think

You must be logged in to comment

What Your Peers Are Saying

Rating: | Brian Maher | March 30, 2012